Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 99.75% institutional investors, 0.96% insiders. Avoro capital advisors is the largest institutional shareholder, holding 9.74% of VERA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.45% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vera Therapeutics	99.75%	0.96%	-0.71%
Sector	Healthcare Stocks	41.88%	10.83%	47.29%
Industry	Biotech Stocks	44.05%	10.78%	45.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Avoro capital advisors	6.21M	9.74%	$180.46M
Blackrock funding, inc. /de	4.25M	6.66%	$123.42M
Blackrock	3.34M	6.55%	$120.76M
Kynam capital management, lp	4.03M	6.31%	$117.05M
Price t rowe associates inc /md/	3.67M	5.75%	$106.55M
Deerfield management company, l.p. (series c)	3.64M	5.71%	$105.81M
Vanguard group	3.19M	5.00%	$92.72M
Fmr	2.84M	4.46%	$82.62M
Eversept partners, lp	2.81M	4.40%	$81.60M
Sofinnova investments	2.79M	4.38%	$81.19M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kynam capital management, lp	4.03M	8.71%	$117.05M
Tri locum partners lp	1.19M	7.95%	$34.59M
Eversept partners, lp	2.81M	5.62%	$81.60M
Portman	32.80K	4.48%	$1.19M
Sofinnova investments	2.79M	4.44%	$81.19M
Capricorn fund managers	450.70K	4.40%	$13.10M
Integral health asset management	1.70M	3.34%	$49.40M
Exome asset management	156.07K	2.75%	$4.54M
Bioimpact capital	563.08K	2.68%	$16.36M
Avoro capital advisors	6.21M	2.33%	$180.46M

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	1.27M	0.06%	1.27M
Tri locum partners lp	1.19M	7.95%	777.09K
Kynam capital management, lp	4.03M	8.71%	600.91K
Integral health asset management	1.70M	3.34%	550.00K
Pfm health sciences, lp	513.68K	1.15%	513.68K

Top Sellers

Holder	Shares	% Assets	Change
Vestal point capital, lp	760.00K	1.00%	-2.34M
Holocene advisors, lp	-	-	-2.20M
Morgan stanley	274.52K	0.00%	-1.96M
Woodline partners lp	737.58K	0.10%	-1.87M
T. rowe price investment management	-	-	-1.68M

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	1.27M	0.06%	1.27M	$36.97M
Pfm health sciences, lp	513.68K	1.15%	513.68K	$14.93M
Braidwell lp	472.74K	0.41%	472.74K	$13.74M
Capricorn fund managers	450.70K	4.40%	450.70K	$13.10M
Hsbc	297.02K	0.00%	297.02K	$8.63M

Sold Out

Holder	Change
Ifp advisors	-1.00
Eversource wealth advisors	-6.00
Coldstream capital management	-6.00
Us bancorp \de\	-6.00
Geowealth management	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	175	-0.57%	63,626,863	5.34%	99	1.11%	96	-6.80%	46	-2.13%
Jun 30, 2025	184	0.55%	63,880,155	2.67%	100	1.05%	108	9.09%	47	-4.08%
Mar 31, 2025	186	1.64%	62,983,082	0.11%	98	0.75%	101	-20.47%	50	35.14%
Dec 31, 2024	174	-2.25%	59,594,280	11.34%	108	1.14%	121	26.04%	35	-30.00%
Sep 30, 2024	178	1.71%	53,475,724	0.91%	97	0.90%	96	-6.80%	50	-10.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	1.56M	2.45%	-117.37K
Vanguard Total Stock Mkt Idx Inv	1.50M	2.36%	-33.34K
Fidelity Growth Compy Commingled Pl O	1.16M	2.11%	-
Vanguard US Total Market Shares ETF	1.33M	2.09%	-2.90K
iShares Russell 2000 ETF	1.24M	1.94%	-
Fidelity Growth Compy Commingled Pl S	1.19M	1.87%	1.63K
T. Rowe Price New Horizons	1.11M	1.74%	-451.62K
Fidelity Growth Company Fund	878.74K	1.38%	-5.26K
SPDR® S&P Biotech ETF	878.00K	1.38%	1.96K
T. Rowe Price Health Sciences	807.03K	1.26%	-362.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 11, 2025	Young Joseph R	SVP, FINANCE, CHIEF ACCT OFFCR	Sell	$435.87K
Jun 24, 2025	ENRIGHT PATRICK G	-	Buy	$302.55K
Jun 23, 2025	ENRIGHT PATRICK G	-	Buy	$1.46M
Jun 23, 2025	ENRIGHT PATRICK G	-	Buy	$2.91M
Jun 24, 2025	ENRIGHT PATRICK G	-	Buy	$605.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	1
2025 Q2	4	-
2025 Q1	-	6
2024 Q4	-	31
2024 Q3	-	21

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 99.75%, followed by 0.96% insiders and -0.71% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 44.05%, which Vera Therapeutics exceeds.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (6.21M shares, 9.74%), Blackrock funding, inc. /de (4.25M shares, 6.66%), and Blackrock (3.34M shares, 6.55%). Together, they hold 22.94% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.71% of its assets in 4.03M Vera Therapeutics shares, valued at 117.05M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Vera Therapeutics shares, with 2.45% of its total shares outstanding invested in 1.56M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools